arrow
N

Nicholas A. Gherardin

Australian Research Council
H指数:30
被引数:6,526

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Specific targeting of MR1-antigen complexes using nanobodies

利用纳米抗体特异性靶向MR1-抗原复合物

2026-09-250
PRE
Sideways lipid presentation by the antigen-presenting molecule CD1c

CD1c抗原提呈分子侧向脂质呈递

2025-12-310
OAAI
The antigen-presenting molecule MR1 binds host-generated riboflavin catabolites

Abdelaal, M.R.; Deng, J.; McInerney, M.P.; Ito, E.; Purcell, A.W.; Yamasaki, S.; Villadangos, J.A.; McWilliam, H.E.G.; Gherardin, N.A.; Rossjohn, J.; et al. 抗原提呈分子MR1结合宿主产生的核黄素代谢物。J. Exp. Med. 2026, 223, e20250711. [Google Scholar] [CrossRef]

2025-11-260
OA
TCR-dependent CD8+T cell responses drive atherosclerotic plaque instability
2025-11-010
PRE
Vγ9Vδ2 T cells recognize butyrophilin 2A1 and 3A1 heteromers

Vγ9vδ2t细胞识别嗜丁基蛋白2A1和3A1异聚体

2024-07-161
PRE
Interim results from a phase I randomized, placebo-controlled trial of novel SARS-CoV-2 beta variant receptor-binding domain recombinant protein and mRNA vaccines as a 4th dose booster
2023-12-015
OAAI
Newborn and child-like molecular signatures in older adults stem from TCR shifts across human lifespan

老年人的新生儿和儿童样分子特征源于人类寿命的TCR变化

2023-09-257
OAAI
Broad immunity to SARS-CoV-2 variants of concern mediated by a SARS-CoV-2 receptor-binding domain protein vaccine

SARS-CoV-2受体结合域蛋白疫苗介导的对SARS-CoV-2相关变异的广泛免疫

2023-06-017
OAAI
Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2 (vol 13, 889372, 2022)

Fc工程ACE2-Fc是一种有效的多功能剂靶向SARS-CoV2 (vol 13,889372,2022)

2023-01-100
OAAI
CD8 coreceptor engagement of MR1 enhances antigen responsiveness by human MAIT and other MR1-reactive T cells
2022-08-2623
OAAI
Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2

Fc工程ACE2-Fc是一种有效的多功能药物靶向SARS-CoV2

2022-07-287
OAAI
Are NKT cells a useful predictor of COVID-19 severity?
IMMUNITY
IF26.3
2022-02-0111
OAAI